XML 74 R50.htm IDEA: XBRL DOCUMENT v3.20.4
EARNINGS (LOSS) PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Earnings Per Share, Basic and Diluted [Abstract]                      
Income from continuing operations                 $ 1,431 $ 838 $ 736
Income from discontinued operations, net of taxes                 0 20 0
Net income attributable to Quest Diagnostics $ 579 $ 568 $ 185 $ 99 $ 253 $ 215 $ 226 $ 164 1,431 858 736
Less: Earnings allocated to participating securities                 6 3 3
Earnings available to Quest Diagnostics’ common stockholders – basic and diluted                 $ 1,425 $ 835 $ 733
Weighted average common shares outstanding - basic                 134 134 136
Stock options and performance share units                 2 2 3
Weighted average common shares outstanding - diluted                 136 136 139
Income from continuing operations (in dollars per share) $ 4.28 $ 4.20 $ 1.38 $ 0.74 $ 1.88 $ 1.59 $ 1.52 $ 1.22 $ 10.62 $ 6.21 $ 5.39
Income from discontinued operations (in dollars per share) 0 0 0 0 0 0 0.15 0 0 0.15 0
Net income (in dollars per share) 4.28 4.20 1.38 0.74 1.88 1.59 1.67 1.22 10.62 6.36 5.39
Income from continuing operations (in dollars per share) 4.21 4.14 1.36 0.73 1.86 1.56 1.51 1.20 10.47 6.13 5.29
Income from discontinued operations (in dollars per share) 0 0 0 0 0 0 0.15 0 0 0.15 0
Net income (in dollars per share) $ 4.21 $ 4.14 $ 1.36 $ 0.73 $ 1.86 $ 1.56 $ 1.66 $ 1.20 $ 10.47 $ 6.28 $ 5.29
Stock options and performance share units not included due to their antidilutive effect                 1 3 2